Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda

Peer Review reports

Original Submission
4 Jan 2021	Submitted	Original manuscript
23 Feb 2021	Reviewed	Reviewer Report
17 Jun 2021	Reviewed	Reviewer Report - Conrad Muzoora
3 Jul 2021	Author responded	Author comments - Frank Mulindwa
Resubmission - Version 2
3 Jul 2021	Submitted	Manuscript version 2
15 Jul 2021	Author responded	Author comments - Frank Mulindwa
Resubmission - Version 3
15 Jul 2021	Submitted	Manuscript version 3
Publishing
9 Aug 2021	Editorially accepted
16 Aug 2021	Article published	10.1186/s12879-021-06533-6

Back to article page